RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Anagliptin twice‐daily regimen improves glycaemic variability in subjects with type 2 diabetes: A d ouble‐blind, randomized controlled trial

Anagliptin twice‐daily regimen improves glycaemic variability in subjects with type 2 diabetes: A d ouble‐blind, randomized controlled trial

Add to Collection
RCTs Y Lee, DM Kim, JM Yu, KM Choi, SG Kim… - Diabetes, Obesity …, 2023 - Wiley Online Library

Chapter : Section9
Journal Year : 2023

… A double‐blinded, randomized, multicentre study was performed in 89 patients with type 2 diabetes treated with metformin alone (6.5% < HbA1c < 8.5%). Subjects were randomly …..... Read More

Keywords : ['anagliptin twicedaily regimen improve glycaemic variability', 'oubleblind randomize control trial', 'type diabetes', 'subject']
PubMed Link : https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/dom.14959